Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Completed 4 Unknown 2 Not yet recruiting 1 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 73 Breast Neoplasms 70 Colorectal Neoplasms 39 Prostatic Neoplasms 37 Carcinoma, Non-Small-Cell Lung 26 Lung Neoplasms 25 Stomach Neoplasms 20 Carcinoma, Hepatocellular 20 Uterine Cervical Neoplasms 19 Pancreatic Neoplasms 15 Anxiety Disorders 15 Leukemia, Myeloid, Acute 14 Hematologic Neoplasms 13 Colonic Neoplasms 13 Brain Neoplasms 13 Urinary Bladder Neoplasms 12 Lymphoma, Follicular 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Head and Neck Neoplasms 11 Esophageal Neoplasms 10 Diabetes Mellitus 10 Ovarian Neoplasms 9 Melanoma 9 Liver Neoplasms 9 Sarcoma 8 Rectal Neoplasms 8 Pulmonary Disease, Chronic Obstructive 8 Multiple Myeloma 8 Esophageal Squamous Cell Carcinoma 8 Disease 8

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Metronidazole 1 Lacteol 1 Esomeprazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × Dysbiosis × Clear all

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡